Display options
Share it on

Front Physiol. 2017 Aug 28;8:630. doi: 10.3389/fphys.2017.00630. eCollection 2017.

β-Adrenergic Inhibition Prevents Action Potential and Calcium Handling Changes during Regional Myocardial Ischemia.

Frontiers in physiology

Shannon R Murphy, Lianguo Wang, Zhen Wang, Philip Domondon, Di Lang, Beth A Habecker, Rachel C Myles, Crystal M Ripplinger

Affiliations

  1. Department of Pharmacology, University of California, DavisDavis, CA, United States.
  2. Department of Biomedical Engineering, University of California, DavisDavis, CA, United States.
  3. Department of Physiology and Pharmacology, Oregon Health & Science UniversityPortland, OR, United States.
  4. Institute of Cardiovascular and Medical Sciences, University of GlasgowGlasgow, United Kingdom.

PMID: 28894423 PMCID: PMC5581400 DOI: 10.3389/fphys.2017.00630

Abstract

β-adrenergic receptor (β-AR) blockers may be administered during acute myocardial infarction (MI), as they reduce energy demand through negative chronotropic and inotropic effects and prevent ischemia-induced arrhythmogenesis. However, the direct effects of β-AR blockers on ventricular electrophysiology and intracellular Ca

Keywords: arrhythmia; beta blocker; calcium; ischemia; sarcoplasmic reticulum

References

  1. Cardiovasc Res. 1984 Nov;18(11):675-82 - PubMed
  2. Proc Natl Acad Sci U S A. 2015 Jun 9;112(23 ):7165-70 - PubMed
  3. Circulation. 2004 May 25;109(20):2469-74 - PubMed
  4. Eur Heart J. 2004 Aug;25(15):1341-62 - PubMed
  5. Cardiovasc Res. 1970 Apr;4(2):141-7 - PubMed
  6. Circulation. 2001 Oct 23;104(17):2082-7 - PubMed
  7. J Physiol. 1992 Feb;447:649-73 - PubMed
  8. Biol Neonate. 2006;90(3):174-84 - PubMed
  9. Eur J Pharmacol. 1993 May 19;236(2):269-77 - PubMed
  10. Lancet. 1984 Oct 20;2(8408):883-6 - PubMed
  11. J Am Coll Cardiol. 2004 May 19;43(10):1780-7 - PubMed
  12. J Vis Exp. 2015 Sep 10;(103):null - PubMed
  13. Eur Heart J. 1985 Nov;6 Suppl D:41-52 - PubMed
  14. Nature. 2002 Jan 10;415(6868):198-205 - PubMed
  15. J Mol Cell Cardiol. 2002 Jan;34(1):39-50 - PubMed
  16. Cardiovasc Res. 2009 Jul 15;83(2):397-404 - PubMed
  17. Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1669-83 - PubMed
  18. J Am Coll Cardiol. 2014 Jun 10;63(22):2356-62 - PubMed
  19. Cardiovasc Res. 2004 May 1;62(2):323-34 - PubMed
  20. Circ Res. 2014 Apr 25;114(9):1410-21 - PubMed
  21. Circulation. 2000 Jun 6;101(22):2645-50 - PubMed
  22. Cardiovasc Res. 2010 Mar 1;85(4):671-80 - PubMed
  23. Fundam Clin Pharmacol. 2014 Jun;28(3):257-67 - PubMed
  24. Am J Physiol Heart Circ Physiol. 2012 Oct 15;303(8):H1047-56 - PubMed
  25. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6954-8 - PubMed
  26. Circ Res. 1984 Nov;55(5):689-701 - PubMed
  27. Heart Rhythm. 2011 Dec;8(12):1963-8 - PubMed
  28. J Mol Cell Cardiol. 1986 Aug;18(8):837-51 - PubMed
  29. Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Feb;71(2 Pt 1):021903 - PubMed
  30. Cardiovasc Res. 1998 Jul;39(1):194-215 - PubMed
  31. Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H400-7 - PubMed
  32. Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H338-H353 - PubMed
  33. J Biol Chem. 2003 Nov 7;278(45):44735-44 - PubMed
  34. Circ Res. 1987 Feb;60(2):194-205 - PubMed
  35. J Mol Cell Cardiol. 1995 May;27(5):1161-72 - PubMed
  36. Heart Rhythm. 2012 Jun;9(6):977-82 - PubMed
  37. J Mol Cell Cardiol. 2009 Aug;47(2):180-7 - PubMed
  38. Int J Cardiol. 2005 Dec 7;105(3):262-6 - PubMed
  39. J Mol Cell Cardiol. 2004 Jan;36(1):67-74 - PubMed
  40. Heart. 2000 Oct;84(4):365-9 - PubMed
  41. Circulation. 2017 Mar 7;135(10 ):e146-e603 - PubMed
  42. J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S37-41 - PubMed
  43. Circ Res. 1996 Dec;79(6):1100-9 - PubMed
  44. Circ Res. 1976 Apr;38(4):302-7 - PubMed

Publication Types

Grant support